ReviewOncotarget2017

Mechanisms of resistance to irreversible epidermal growth factor receptor tyrosine kinase inhibitors and therapeutic strategies in non-small cell lung cancer.

Jing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.